John S. Link

1.9k total citations
23 papers, 862 citations indexed

About

John S. Link is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, John S. Link has authored 23 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in John S. Link's work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). John S. Link is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). John S. Link collaborates with scholars based in United States, Taiwan and Belgium. John S. Link's co-authors include James Waisman, Makoto Ohori, Thomas M. Wheeler, Peter T. Scardino, Robert Alan Nagourney, Steven S. Evans, Mary L. Disis, Doreen M. Higgins, Andrew L. Coveler and Jennifer S. Childs and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

John S. Link

22 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Link United States 13 487 287 250 150 141 23 862
Richard G. Phelps United Kingdom 12 229 0.5× 218 0.8× 149 0.6× 48 0.3× 110 0.8× 19 722
Jeffrey Allard United States 10 336 0.7× 176 0.6× 206 0.8× 168 1.1× 178 1.3× 14 759
Johannes Ludwig Germany 18 504 1.0× 343 1.2× 145 0.6× 158 1.1× 269 1.9× 70 1.3k
Jerry L. Klein United States 20 265 0.5× 201 0.7× 211 0.8× 528 3.5× 347 2.5× 42 1.2k
Rosamma DeCastro United States 11 481 1.0× 319 1.1× 161 0.6× 31 0.2× 246 1.7× 15 1.2k
Joseph Baar United States 16 423 0.9× 272 0.9× 539 2.2× 99 0.7× 362 2.6× 32 1.2k
Steven K. Seung United States 13 509 1.0× 219 0.8× 379 1.5× 112 0.7× 91 0.6× 24 831
Christophe Perrin France 13 272 0.6× 444 1.5× 50 0.2× 102 0.7× 133 0.9× 40 897
Robert A. Ambros United States 23 485 1.0× 311 1.1× 108 0.4× 133 0.9× 419 3.0× 40 1.6k
Francesca Moretta Italy 22 719 1.5× 193 0.7× 1.2k 4.7× 43 0.3× 182 1.3× 36 1.7k

Countries citing papers authored by John S. Link

Since Specialization
Citations

This map shows the geographic impact of John S. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Link more than expected).

Fields of papers citing papers by John S. Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Link. The network helps show where John S. Link may publish in the future.

Co-authorship network of co-authors of John S. Link

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Link. A scholar is included among the top collaborators of John S. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Link. John S. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiu, Joanne, Zoran Gatalica, Priscilla Reddy, James Waisman, & John S. Link. (2016). Abstract P3-07-27: Distinct biomarker features in triple-negative breast cancer metastases to the brain, liver and bone. Cancer Research. 76(4_Supplement). P3–7.
2.
Stanton, Annette L., Elizabeth H. Thompson, Catherine M. Crespi, John S. Link, & James Waisman. (2013). Project Connect Online: Randomized Trial of an Internet-Based Program to Chronicle the Cancer Experience and Facilitate Communication. Journal of Clinical Oncology. 31(27). 3411–3417. 33 indexed citations
3.
Mankoff, David A., John S. Link, Brenda F. Kurland, et al.. (2011). NCI-sponsored phase II study of [18f]fluoroestradiol (FES) as a marker of hormone sensitivity of metastatic breast cancer: Initial results.. Journal of Clinical Oncology. 29(15_suppl). e11104–e11104. 1 indexed citations
4.
Capri, Giuseppe, José Chang, Pierfranco Conté, et al.. (2009). An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer. Annals of Oncology. 21(3). 474–480. 64 indexed citations
5.
Disis, Mary L., Danelle R. Wallace, Theodore A. Gooley, et al.. (2009). Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer. Journal of Clinical Oncology. 27(28). 4685–4692. 224 indexed citations
6.
Goodell, Vivian, James Waisman, Lupe G. Salazar, et al.. (2008). Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity. Molecular Cancer Therapeutics. 7(3). 449–454. 42 indexed citations
7.
Nagourney, Robert Alan, Marshall S. Flam, John S. Link, et al.. (2008). Carboplatin plus Gemcitabine Repeating Doublet Therapy in Recurrent Breast Cancer. Clinical Breast Cancer. 8(5). 432–435. 16 indexed citations
8.
Link, John S., et al.. (2007). Bevacizumab and Albumin-Bound Paclitaxel Treatment in Metastatic Breast Cancer. Clinical Breast Cancer. 7(10). 779–783. 26 indexed citations
9.
Link, John S., et al.. (2007). Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer. Journal of Clinical Oncology. 25(18_suppl). 1101–1101. 3 indexed citations
10.
Nagourney, Robert Alan, et al.. (2004). Carboplatin & gemcitabine repeating doublet in recurrent breast cancer. Journal of Clinical Oncology. 22(14_suppl). 851–851. 4 indexed citations
11.
Link, John S.. (2000). History and Overview of Comprehensive Interdisciplinary Breast Centers. Surgical Oncology Clinics of North America. 9(2). 147–157. 10 indexed citations
12.
Nagourney, Robert Alan, et al.. (2000). Gemcitabine Plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Breast Cancer Patients. Journal of Clinical Oncology. 18(11). 2245–2249. 95 indexed citations
13.
Pullarkat, Vinod, Yashwant M. Deo, John S. Link, et al.. (1999). A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu. Cancer Immunology Immunotherapy. 48(1). 9–21. 41 indexed citations
14.
West, John G., et al.. (1997). A breast cancer care report card. An assessment of performance and a pursuit of value.. Europe PMC (PubMed Central). 166(4). 248–52. 8 indexed citations
15.
Ohori, Makoto, et al.. (1993). The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer. The American Journal of Surgical Pathology. 17(12). 1252–1261. 163 indexed citations
16.
Link, John S., et al.. (1991). Improved mammographic accuracy. American Journal of Obstetrics and Gynecology. 164(6). 1643–1646. 3 indexed citations
17.
Meinkoth, James H., John P. Hoover, Rick L. Cowell, Ronald D. Tyler, & John S. Link. (1989). Ehrlichiosis in a dog with seizures and nonregenerative anemia. Journal of the American Veterinary Medical Association. 195(12). 1754–1755. 17 indexed citations
18.
Sarver, Nava, George A. Ricca, John S. Link, et al.. (1987). Stable Expression of Recombinant Factor VIII Molecules Using a Bovine Papillomavirus Vector. DNA. 6(6). 553–564. 22 indexed citations
19.
Sun, Nian X., et al.. (1978). Melanoma in a Patient Treated for Psoriasis. Southern Medical Journal. 71(6). 732–732. 8 indexed citations
20.
Link, John S., et al.. (1977). 5-Fluorouracil in hepatocellular carcinoma.Report of twenty-one cases. Cancer. 39(5). 1936–1939. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard G. Phelps Breakdown of academic impact, for papers by Jeffrey Allard Breakdown of academic impact, for papers by Johannes Ludwig Breakdown of academic impact, for papers by Jerry L. Klein Breakdown of academic impact, for papers by Rosamma DeCastro Breakdown of academic impact, for papers by Joseph Baar Breakdown of academic impact, for papers by Steven K. Seung Breakdown of academic impact, for papers by Christophe Perrin Breakdown of academic impact, for papers by Robert A. Ambros Breakdown of academic impact, for papers by Francesca Moretta
Rankless by CCL
2026